These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19812251)

  • 1. A mutation associated with CMT2A neuropathy causes defects in Fzo1 GTP hydrolysis, ubiquitylation, and protein turnover.
    Amiott EA; Cohen MM; Saint-Georges Y; Weissman AM; Shaw JM
    Mol Biol Cell; 2009 Dec; 20(23):5026-35. PubMed ID: 19812251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.
    Franco A; Dang X; Zhang L; Molinoff PB; Dorn GW
    J Pharmacol Exp Ther; 2022 Nov; 383(2):137-148. PubMed ID: 36507849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ugo1 and Mdm30 act sequentially during Fzo1-mediated mitochondrial outer membrane fusion.
    Anton F; Fres JM; Schauss A; Pinson B; Praefcke GJ; Langer T; Escobar-Henriques M
    J Cell Sci; 2011 Apr; 124(Pt 7):1126-35. PubMed ID: 21385840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion.
    Cohen MM; Amiott EA; Day AR; Leboucher GP; Pryce EN; Glickman MH; McCaffery JM; Shaw JM; Weissman AM
    J Cell Sci; 2011 May; 124(Pt 9):1403-10. PubMed ID: 21502136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations.
    Amiott EA; Lott P; Soto J; Kang PB; McCaffery JM; DiMauro S; Abel ED; Flanigan KM; Lawson VH; Shaw JM
    Exp Neurol; 2008 May; 211(1):115-27. PubMed ID: 18316077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MITOL-mediated DRP1 ubiquitylation and degradation promotes mitochondrial hyperfusion in a CMT2A-linked MFN2 mutant.
    Das R; Kamal IM; Das S; Chakrabarti S; Chakrabarti O
    J Cell Sci; 2022 Jan; 135(2):. PubMed ID: 34870686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A.
    Franco A; Dang X; Walton EK; Ho JN; Zablocka B; Ly C; Miller TM; Baloh RH; Shy ME; Yoo AS; Dorn GW
    Elife; 2020 Oct; 9():. PubMed ID: 33074106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset.
    Li YJ; Cao YL; Feng JX; Qi Y; Meng S; Yang JF; Zhong YT; Kang S; Chen X; Lan L; Luo L; Yu B; Chen S; Chan DC; Hu J; Gao S
    Nat Commun; 2019 Oct; 10(1):4914. PubMed ID: 31664033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of a GTPase conformational switch for membrane fusion by mitofusin ubiquitylation.
    Schuster R; Anton V; Simões T; Altin S; den Brave F; Hermanns T; Hospenthal M; Komander D; Dittmar G; Dohmen RJ; Escobar-Henriques M
    Life Sci Alliance; 2020 Jan; 3(1):. PubMed ID: 31857350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity in salt bridge allows fusion-competent ubiquitylation of mitofusins and Cdc48 recognition.
    Anton V; Buntenbroich I; Schuster R; Babatz F; Simões T; Altin S; Calabrese G; Riemer J; Schauss A; Escobar-Henriques M
    Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31740565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mfn2
    Zhang Y; Ma L; Wang Z; Gao C; Yang L; Li M; Tang X; Yuan H; Pang D; Ouyang H
    Int J Biol Macromol; 2024 Oct; 278(Pt 1):134673. PubMed ID: 39142491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
    Franco A; Li J; Kelly DP; Hershberger RE; Marian AJ; Lewis RM; Song M; Dang X; Schmidt AD; Mathyer ME; Edwards JR; Strong CG; Dorn GW
    Elife; 2023 Nov; 12():. PubMed ID: 37910431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MFN2 mutations cause severe phenotypes in most patients with CMT2A.
    Feely SM; Laura M; Siskind CE; Sottile S; Davis M; Gibbons VS; Reilly MM; Shy ME
    Neurology; 2011 May; 76(20):1690-6. PubMed ID: 21508331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torin1 restores proliferation rate in Charcot-Marie-Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation.
    Zanfardino P; Amati A; Petracca EA; Santorelli FM; Petruzzella V
    Acta Myol; 2022; 41(4):201-206. PubMed ID: 36793649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
    Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
    J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro.
    Stavropoulos F; Georgiou E; Schiza N; Bell S; Baloh RH; Kleopa KA; Sargiannidou I
    J Peripher Nerv Syst; 2023 Sep; 28(3):329-340. PubMed ID: 37220142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth type 2A in vivo models: Current updates.
    Abati E; Rizzuti M; Anastasia A; Comi GP; Corti S; Rizzo F
    J Cell Mol Med; 2024 May; 28(9):e18293. PubMed ID: 38722298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations.
    Detmer SA; Chan DC
    J Cell Biol; 2007 Feb; 176(4):405-14. PubMed ID: 17296794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of a Novel c.820C>T (Arg274Trp) Mutation in the Mitofusin 2 Gene on Fibroblast Metabolism and Clinical Manifestation in a Patient.
    Beręsewicz M; Boratyńska-Jasińska A; Charzewski Ł; Kawalec M; Kabzińska D; Kochański A; Krzyśko KA; Zabłocka B
    PLoS One; 2017; 12(1):e0169999. PubMed ID: 28076385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.